CLINICAL_TRIALS
research
· 2026-04-13
Clinical Trial Update: KSD-101 in Patients With EBV-associated Hematological Malignancies
Summary
Clinical trial update for KSD-101 in Epstein-Barr virus-associated lymphoid neoplasms; the study (NCT07525024) is currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ruijin Hospital | Conditions: EBV Associated Lymphoid Neoplasms | Status: NOT_YET_RECRUITING